Castle Biosciences outlines $33B AdvanceAD-Tx market opportunity while raising 2025 revenue guidance (NASDAQ:CSTL)
Group 1 - The article does not provide any specific information or insights regarding a company or industry [1]
Group 1 - The article does not provide any specific information or insights regarding a company or industry [1]